Webinar on the Implanted Brain-Computer Interface (BCI) Final Guidance

Join us on Thursday, July 29, 2021, at 11 am for the Implanted BCI Devices Final Guidance Webinar

If your email program has trouble displaying this email, view as a webpage. Join Us: Implanted Brain-Computer Interface Devices for Patients with Paralysis or Amputation –  Webinar On Thursday, July 29 at 11 am ET, the U.S. Food and Drug Administration (FDA), will host a webinar for stakeholders interested in learning about the final guidance on Implanted Brain-Computer Interface (BCI) Devices for Patients with Paralysis or Amputation – Non-clinical Testing and Clinical Considerations. During this webinar, the FDA will answer questions from webinar attendees in an open question and answer format. We encourage all interested stakeholders to join. There is no registration for this webinar. Please call in 15 minutes before the start of the webinar to allow time to connect. U.S. Callers Dial: 888-455-1392 Conference Number: PWXW2194155 Passcode: 2162844 International Callers Dial: 1-773-799-3847            Conference Number: PWXW2194155 Passcode: 2162844 To view the slide presentation during the webinar: https://www.mymeetings.com/nc/join.php?i=PWXW2194155&p=2162844&t=c View the Webinar Details Questions If you have a general question about this final guidance, contact the Division of Industry and Consumer Education.

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA